CLICK CHEMISTRY AND BIOORTHOGONAL CHEMISTRY: REVOLUTIONIZING DRUG DELIVERY

Click Chemistry was first coined by Karl Barry Sharpless at the 217th ACS National Meeting in 1999.1 It refers to a chemical synthesis approach wherein molecular building blocks combine efficiently and selectively, generating no or fewer by-products that can be easily purified without chromatographic separation techniques. Notably, there are various types of click chemistry reactions; amongst these, bioorthogonal chemistry is most prominently employed in biological systems without altering the molecule of interest.

Click and bioorthogonal reactions can be used in the production of therapeutic modalities and as probes in medical imaging techniques in order to aid in the development of treatment options for various oncological and non-oncological disorders. It is worth highlighting that in 2022, Carolyn R. Bertozzi, Karl Barry Sharpless and Morten Meldal were honored with "Noble Prize in Chemistry" for the development of click chemistry and bioorthogonal chemistry approach. A click reaction usually happens by combining an azide with a cyclooctyne, forming a conjugated biomolecule. The resulting molecule can be used as a probe to identify biomarkers in living beings.

The click chemistry and bioorthogonal chemistry market, valued at USD 1.04 billion in 2025, is projected to reach USD 1.14 billion in 2026 and USD 3.65 billion by 2040, with a 8.7% CAGR during the forecast period 2026 to 2040.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/click-chemistry-and-bioorthogonal-chemistry-market/request-quote.html

Click Chemistry and Bioorthogonal Chemistry: Market Landscape

The current market landscape features the presence of close to 35 companies providing click chemistry services to cater to the needs of various industries, primarily pharmaceutical and biotechnology sectors. The click chemistry and bioorthogonal chemistry market is primarily driven by the presence of well-established players in Europe, primarily in countries, such as Germany and France. Presently, over 80% of the firms are offering custom synthesis services; of these, over 20% of the firms are utilizing SPAAC click reaction for synthesizing and labeling different molecules. This can be primarily attributed to the fact that SPAAC reactions do not require copper catalyst, thus eliminating toxicity issues.

To request a sample copy / brochure of this report, please visit:
https://www.rootsanalysis.com/reports/click-chemistry-and-bioorthogonal-chemistry-market/request-sample.html

In pursuit of building a competitive edge, stakeholders are actively upgrading their existing capabilities to enhance their technology portfolios and comply with the evolving industry benchmarks

In order to determine the relative competitiveness of click chemistry and bioorthogonal chemistry technologies, we focused on several relevant parameters, such as technology provider strength (in terms of overall years of experience, company size and type of business strategy adopted), and portfolio strength (in terms of type of click chemistry reaction, type of molecule synthesized / labeled, therapeutic area and application area).

Various firms in the click chemistry and bioorthogonal chemistry domain are increasingly entering into collaborations with local and international players to expand their capabilities, leverage complementary expertise and access new markets

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/click-chemistry-and-bioorthogonal-chemistry-market.html#overview

The rising interest in the click chemistry and bioorthogonal chemistry domain is reflected in the wide array of partnerships established between various stakeholders in the recent past. Most of the deals in this domain were inked with industry players; of these, majority of deals signed were focused on drug discovery. During the specified time frame, over 50% of the deals inked between stakeholders were focused on technology or product licensing; of these, over 80% were focused on the development of novel ADCs.

Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/

About Roots Analysis
Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.